Abstract
Qiaoya Tang
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Clinical guidelines for the prevention and treatment of preterm birth (2024 edition)
2024
Unresolved referenced work
2023
Placenta growth factor: identification and characterization of a novel isoform generated by RNA alternative splicing
10.1006/bbrc.1997.6813 · 1997
Preeclampsia is associated with reduced serum levels of placenta growth factor
10.1016/s0002-9378(98)70021-3 · 1998
PlGF (placental growth factor) testing in clinical practice: evidence from a Canadian tertiary maternity referral center
10.1161/hypertensionaha.121.17047 · 2021
Placental growth factor testing to assess women with suspected pre‐eclampsia: a multicentre, pragmatic, stepped‐wedge cluster‐randomised controlled trial
10.1016/s0140-6736(18)33212-4 · 2019
Diagnostic accuracy of placental growth factor in women with suspected preeclampsia: a prospective multicenter study
10.1161/circulationaha.113.003215 · 2013
The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre‐eclampsia: a pragmatic guide for first‐trimester screening and prevention
10.1002/ijgo.12802 · 2019
Contingent screening for preterm pre‐eclampsia
10.1002/uog.15807 · 2016
Guideline for the prediction and prevention of pre‐eclampsia (2025)
2025
Is serum placental growth factor more effective as a biomarker in predicting early onset preeclampsia in early second trimester than in first trimester of pregnancy?
10.1007/s00404-012-2662-2 · 2013
Association between placental growth factor levels in early onset preeclampsia with the occurrence of postpartum hemorrhage: a prospective cohort study
10.1016/j.preghy.2011.11.006 · 2012
First‐trimester PlGF and PAPP‐A and the risk of placenta‐mediated complications: PREDICTION prospective study
2024
Placental growth factor and fetoplacental doppler indices in combination predict preterm birth reliably in pregnancies complicated by fetal growth restriction
10.1002/uog.27513 · 2024
Circulating biomarkers associated with placental dysfunction and their utility for predicting fetal growth restriction
10.1042/cs20220300 · 2023
Imbalances in circulating angiogenic factors in the pathophysiology of preeclampsia and related disorders
10.1016/j.ajog.2020.10.022 · 2022
Clinical utility of sFlt‐1 and PlGF in screening, prediction, diagnosis and monitoring of pre‐eclampsia and fetal growth restriction
10.1002/uog.26032 · 2023
Association of placental growth factor with the risk of adverse pregnancy outcomes: a prospective cohort study in Chinese pregnant women
10.3389/fendo.2025.1674540 · 2025
Midpregnancy placental growth factor screening and early preterm birth
10.1001/jamanetworkopen.2024.44454 · 2024
Serum screening in first trimester to predict pre‐eclampsia, small for gestational age and preterm delivery: systematic review and meta‐analysis
2015
Maternal serum levels of soluble fms‐like tyrosine kinase‐1 and placental growth factor at 20 and 28 weeks of gestational age and the risk of spontaneous preterm birth
10.1016/j.ajog.2023.02.001 · 2023
Clinical effectiveness of routine first‐trimester combined screening for pre‐eclampsia in Spain with the addition of placental growth factor
10.1111/aogs.14687 · 2023
10.1159/000514201
10.1159/000514201
10.1056/nejmoa1414838
10.1056/nejmoa1414838
10.1038/s41581-019-0119-6
10.1038/s41581-019-0119-6
No additional external references are available.